Publications

This kit includes information and communication resources you can share with your community to raise awareness about the risks of RSV in young children and the benefits of vaccination during pregnancy.

Social media tile about talking to your heath professional about maternal vaccinations.

Social media tile about the RSV maternal vaccine.

Social media tile about the free RSV vaccine in pregnancy.

Social media tile about the free RSV vaccine in pregnancy.

Social media tile about protecting your newborn with a RSV vaccine in pregnancy.

Social media tile about protecting babies from RSV with the maternal vaccination.

Getting vaccinated against RSV between 28 and 36 weeks of pregnancy protects your newborn baby against respiratory syncytical virus (RSV). Yarn to your midwife or health worker about getting your free RSV vaccination.

This social media tile can be used for sharing information on whooping cough vaccinations for Aboriginal and Torres Strait Islander women during pregnancy.

This social media tile can be used for sharing information on flu vaccinations for Aboriginal and Torres Strait Islander women during pregnancy.

This social media tile can be used for sharing information on vaccinations for Aboriginal and Torres Strait Islander women during pregnancy.

This fact sheet provides information for Aboriginal and Torres Strait Islander women about free vaccines during pregnancy.

Download this poster and display in your Aboriginal and Torres Strait Islander health clinics or medical centres.

This poster provides information about maternal vaccinations under the National Immunisation Program.

This fact sheet provides information to consumers on the maternal RSV vaccine and infant RSV immunisation products.

The Cube Group and the Department evaluated the Pregnancy, Birth and Baby (PBB) service. Delivered by Healthdirect Australia, PBB is a national service providing support and information for expecting mothers and parents, families, and carers of children from birth to 5 years of age.

This document contains a summary of Marketing in Australia of Infant Formulas (MAIF) complaint outcomes from financial year 2023–24.

The best way to protect you and your baby is to stop smoking and vaping.

This report is the Australian Government response to the recommendations made by the Senate Community Affairs References Committee.

The list of variants for sickle cell disease, beta thalassemia and other hemoglobinopathies are captured in this resource.

This evaluation captures AFPP outcomes and it’s impact on the health and wellbeing of participating families, and identifies areas for improvement.

The Annual Report 2023–2024 of the Marketing in Australia of Infant Formula (MAIF) Agreement Complaints Committee contains information about the function of the committee and complaints received in relation to the MAIF Agreement.

This is the third Annual Report for the monitoring and evaluation of the National Stillbirth Action and Implementation Plan (Stillbirth Action Plan). The report looks at the implementation of tasks in the Stillbirth Action Plan that contribute to the overarching goals.

This 2022-23 annual report of the Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee contains information about complaints the committee received in relation to the MAIF Agreement.

This 2021-22 annual report of the Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee contains information about complaints the committee received in relation to the MAIF Agreement.